CCR5 Monoclonal Antibodies for HIV-1 Therapy

Por Olson, William C., Jacobson, Jeffrey M.
Publicado em 2009

Purulent Pericarditis Caused by Haemophilus parainfluenzae

Por Latyshev, Yevgeniy, Mathew, Aswin, Jacobson, Jeffrey M., Sturm, Eron
Publicado em 2013

The Critical Need for Alternative Antiretroviral Formulations, and Obstacles to Their Development

Por Swindells, Susan, Flexner, Charles, Fletcher, Courtney V., Jacobson, Jeffrey M.
Publicado em 2011

Body Mass Index and CD4+ T-Lymphocyte Recovery in HIV-Infected Men with Viral Suppression on Antiretroviral Therapy

Por Palermo, Brandon, Bosch, Ronald J., Bennett, Kara, Jacobson, Jeffrey M.
Publicado em 2011

New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists

Por Schlecht, Hans P, Schellhorn, Sarah, Dezube, Bruce J, Jacobson, Jeffrey M
Publicado em 2008

HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure

Por Dampier, Will, Nonnemacher, Michael R., Sullivan, Neil T., Jacobson, Jeffrey M., Wigdahl, Brian
Publicado no MOJ Immunol (2014)

HIV- and AIDS-Related Knowledge, Awareness, and Practices in Madagascar

Por Lanouette, Nicole M., Noelson, Rivo, Ramamonjisoa, Andriamahenina, Jacobson, Sheldon, Jacobson, Jeffrey M.
Publicado em 2003

Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection

Por Pirrone, Vanessa, Thakkar, Nina, Jacobson, Jeffrey M., Wigdahl, Brian, Krebs, Fred C.
Publicado em 2011

Ultra-Fast Low Concentration Detection of Candida Pathogens Utilizing High Resolution Micropore Chips

Por Mulero, Rafael, Lee, Dong Heun, Kutzler, Michele A., Jacobson, Jeffrey M., Kim, Min Jun
Publicado em 2009

Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation

Por Bednar, Maria M., Hauser, Blake M., Zhou, Shuntai, Jacobson, Jeffrey M., Eron, Joseph J., Frank, Ian, Swanstrom, Ronald
Publicado no J Infect Dis (2016)

Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-In...

Por Jacobson, Jeffrey M., Kuritzkes, Daniel R., Godofsky, Eliot, DeJesus, Edwin, Larson, Jeffrey A., Weinheimer, Steven P., Lewis, Stanley T.
Publicado em 2009

CD8+ T-cell Activation in HIV-1-Infected Patients Experiencing Transient Low-level Viremia During Antiretroviral Therapy

Por Taiwo, Babafemi, Hunt, Peter W., Gandhi, Rajesh T., Ellingson, Andrew, McKenna, Matthew, Jacobson, Jeffrey M., Gripshover, Barbara, Bosch, Ronald J.
Publicado em 2013

Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatients at a Community Care Center

Por Rajagopalan, Nirmala, Suchitra, Joyce B., Shet, Anita, Khan, Zafar K., Martin-Garcia, Julio, Nonnemacher, Michael R., Jacobson, Jeffrey M., Wigdahl, Brian
Publicado em 2009

Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection

Por Jacobson, Jeffrey M., Feinman, Lawrence, Liebes, Leonard, Ostrow, Nancy, Koslowski, Victoria, Tobia, Alfonso, Cabana, Bernard E., Lee, Dong-Hun, Spritzler, John, Prince, Alfred M.
Publicado em 2001

Cocaine Alters Cytokine Profiles in HIV-1-Infected African American Individuals in the DrexelMed HIV/AIDS Genetic Analysis Cohort

Por Parikh, Nirzari, Dampier, Will, Feng, Rui, Passic, Shendra R., Zhong, Wen, Frantz, Brian, Blakey, Brandon, Aiamkitsumrit, Benjamas, Pirrone, Vanessa, Nonnemacher, Michael R., Jacobson, Jeffrey M., Wigdahl, Brian
Publicado em 2014

Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine

Por Latimer, Brian, Toporovski, Roberta, Yan, Jian, Pankhong, Panyupa, Morrow, Matthew P, Khan, Amir S, Sardesai, Niranjan Y, Welles, Seth L, Jacobson, Jeffrey M, Weiner, David B, Kutzler, Michele A
Publicado no Hum Vaccin Immunother (2014)

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients

Por Dampier, Will, Nonnemacher, Michael R., Mell, Joshua, Earl, Joshua, Ehrlich, Garth D., Pirrone, Vanessa, Aiamkitsumrit, Benjamas, Zhong, Wen, Kercher, Katherine, Passic, Shendra, Williams, Jean W., Jacobson, Jeffrey M., Wigdahl, Brian
Publicado no PLoS One (2016)

Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody

Por Jacobson, Jeffrey M., Thompson, Melanie A., Lalezari, Jacob P., Saag, Michael S., Zingman, Barry S., D’Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.
Publicado em 2010

Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248

Por Andrade, Adriana, Rosenkranz, Susan L., Cillo, Anthony R., Lu, Darlene, Daar, Eric S., Jacobson, Jeffrey M., Lederman, Michael, Acosta, Edward P., Campbell, Thomas, Feinberg, Judith, Flexner, Charles, Mellors, John W., Kuritzkes, Daniel R.
Publicado em 2013

Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures

Por Antell, Gregory C., Dampier, Will, Aiamkitsumrit, Benjamas, Nonnemacher, Michael R., Jacobson, Jeffrey M., Pirrone, Vanessa, Zhong, Wen, Kercher, Katherine, Passic, Shendra, Williams, Jean W., Schwartz, Gregory, Hershberg, Uri, Krebs, Fred C., Wigdahl, Brian
Publicado no Retrovirology (2016)